Approvals/CIMA-AEMPS/PAZOPANIB GLENMARK 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

Approved

STANDARD

PAZOPANIB GLENMARK 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

Glenmark Arzneimittel Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: e9e2e07bdd0f371c
Drug Cima Aemps Name: PAZOPANIB GLENMARK 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Register Number: 89787
Holder Company Name: Glenmark Arzneimittel Gmbh
Marketing Company Name: Glenmark Farmaceutica S.L.U
Holder Company Detail Path: /organization/glenmark-arzneimittel-gmbh
Authorization Date: 2024-12-16
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 400 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Glenmark Arzneimittel Gmbh
Company Detail Path: /organization/glenmark-arzneimittel-gmbh

PAZOPANIB HIDROCLORURO

433,40 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 16, 2024

Approval ID

e9e2e07bdd0f371c

Type

Standard